Pharmacokinetic and Pharmacodynamic Responses to Clopidogrel: Evidences and Perspectives

Clopidogrel has significantly reduced the incidence of recurrent atherothrombotic events in patients with acute coronary syndrome (ACS) and in those undergoing percutaneous coronary intervention (PCI). However, recurrence events still remain, which may be partly due to inadequate platelet inhibition...

Full description

Bibliographic Details
Main Authors: Yan-Jiao Zhang, Mu-Peng Li, Jie Tang, Xiao-Ping Chen
Format: Article
Language:English
Published: MDPI AG 2017-03-01
Series:International Journal of Environmental Research and Public Health
Subjects:
Online Access:http://www.mdpi.com/1660-4601/14/3/301